London And Hamilton

Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors

NEW YORK, LONDON and HAMILTON, Bermuda, April 22, 2010 - Celtic Pharmaceutical Holdings L.P.

NEW YORK, LONDON and HAMILTON, Bermuda, January 21 - Celtic Pharmaceutical Holdings L.P.